Refreshing results…
Efficacy and safety of immune checkpoint inhibitors in young adults with metastatic melanoma
UploadT cells specific for α-myosin drive immunotherapy-related myocarditis
Download from www.nature.comHarnessing big data to characterize immune-related adverse events
UploadBRAF internal deletions and resistance to BRAF/MEK inhibitor therapy
Download from europepmc.orgA phase II trial of erlotinib and bevacizumab for patients with metastatic melanoma
UploadMissing publications? Search for publications with a matching author name.